Second-line platinum-based chemotherapy after enfortumab vedotin plus pembrolizumab in advanced urothelial carcinoma: a systematic review
Year: 2026
Type: preprint
Abstract: Materials for a systematic review of second-line platinum-based chemotherapy after first-line enfortumab vedotin plus pembrolizumab in locally advanced or metastatic urothelial carcinoma.
Source: OSF Preprints (OSF Preprints)
Author: Shugo Yajima
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7233910833
